M
美加康
HEALTH GUIDE8/1/2026

Colorectal Cancer Treatment in Shanghai: 2026 International Patient Guide

Colorectal cancer in Shanghai — Zhongshan, Changhai, Renji; robotic/da Vinci surgery, ISR sphincter-preserving surgery, RAS/BRAF targeted therapy, liver metastasis MDT.

colorectal cancerShanghai hospitalrobotic surgeryISRTMEliver metastasis

Shanghai's Colorectal Expertise

Shanghai's leading colorectal centers perform thousands of procedures annually. Key strengths include robotic surgery (da Vinci), ISR (intersphincteric resection) for ultra-low rectal cancer preserving the anus, CME/TME gold-standard surgery, and multidisciplinary management of liver metastases.

Top Hospitals

  • Zhongshan Hospital, Fudan — Prof. Xu Jianmin (许剑民), minimally invasive surgery and comprehensive care; leading colorectal liver metastasis program.
  • Changhai Hospital (Navy Medical University) — Dr. Gong Haifeng (龚海峰), 8000+ cases, da Vinci certified, shortest hospital stay in Shanghai.
  • Renji Hospital — Dr. Yu Minhao (俣旻皓), metastatic/recurrent complex colorectal cancer MDT.
  • Xinhua Hospital — Dr. Wang Zhongchuan (王中川), CME/TME, extreme sphincter preservation, 300+ cases/year.
  • Shanghai East Hospital (Tongji) — Prof. Song Chun (宋纯), surgery-drug bridging therapy.
  • Treatment by Stage

  • Early (I-II): Laparoscopic/robotic colectomy or TME/ISR for rectal cancer.
  • Locally advanced rectal: Neoadjuvant chemoradiation (nCRT) or total neoadjuvant therapy (TNT) followed by TME.
  • Metastatic (IV): RAS/BRAF testing; EGFR antibodies (cetuximab) for RAS wild-type left-sided; bevacizumab; HER2-targeted therapy for HER2+ mCRC; liver/lung metastasectomy when resectable.
  • Sphincter Preservation

    For ultra-low rectal cancer (within 3-5 cm from anal verge), ISR can avoid permanent colostomy in selected patients. Shanghai surgeons have extensive experience with this technically demanding procedure.

    Cost Reference

    Robotic colorectal surgery: ¥80,000–130,000. Colon/rectal resection (laparoscopic): ¥60,000–100,000. Chemotherapy: ¥8,000–30,000/cycle. Targeted therapy (cetuximab/bevacizumab): ¥15,000–40,000/month depending on insurance coverage.

    Disclaimer: This article is for informational purposes only. Individual outcomes vary. Always consult with qualified medical professionals before making treatment decisions. Contact MedBridge Shanghai for personalized consultation.

    Ready to Start Your Medical Journey?

    Free consultation with our medical experts. Get a personalized treatment plan within 48 hours.

    Free Consultation